$GTCB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in rEVO Biologics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in rEVO Biologics, Inc.. Get notifications about new insider transactions in rEVO Biologics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 0.87 | 2,155 | 1,875 | 10,655 | 8.5 K to 10.7 K (+25.35 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.87 | 5,747 | 5,000 | 18,415 | 12.7 K to 18.4 K (+45.37 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 0.87 | 3,161 | 2,750 | 86,946 | 83.8 K to 86.9 K (+3.77 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 0.87 | 1,149 | 1,000 | 6,683 | 5.5 K to 6.7 K (+20.76 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 0.87 | 1,500 | 1,304 | 83,785 | 82.3 K to 83.8 K (+1.82 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 0.87 | 1,700 | 1,478 | 82,285 | 80.6 K to 82.3 K (+2.11 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 0.87 | 5,400 | 4,697 | 80,585 | 75.2 K to 80.6 K (+7.18 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 0.87 | 1,400 | 1,216 | 75,185 | 73.8 K to 75.2 K (+1.90 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | GRAY MARY ANN | Director | Buy | P | 0.88 | 10,000 | 8,800 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Buy | P | 0.89 | 1,200 | 1,068 | 65,334 | 64.1 K to 65.3 K (+1.87 %) |
| Dec 17 2007 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Buy | P | 0.87 | 1,100 | 957 | 34,648 | 33.5 K to 34.6 K (+3.28 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Buy | P | 0.89 | 1,500 | 1,334 | 87,200 | 85.7 K to 87.2 K (+1.75 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Buy | P | 0.90 | 10,000 | 9,000 | 99,226 | 89.2 K to 99.2 K (+11.21 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.88 | 900 | 792 | 253,982 | 253.1 K to 254 K (+0.36 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.89 | 1,000 | 889 | 253,082 | 252.1 K to 253.1 K (+0.40 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.89 | 7,865 | 7,000 | 252,082 | 244.2 K to 252.1 K (+3.22 %) |
| Dec 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.90 | 1,000 | 900 | 244,217 | 243.2 K to 244.2 K (+0.41 %) |
| Dec 10 2007 | GTCB | rEVO Biologics, In ... | GRAY MARY ANN | Director | Option Exercise | A | 0.93 | 15,000 | 13,950 | 15,000 | |
| Oct 10 2007 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.88 | 1,260 | 1,114 | 53,636 | 52.4 K to 53.6 K (+2.41 %) |
| Oct 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.88 | 1,253 | 1,108 | 243,217 | 242 K to 243.2 K (+0.52 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 1.02 | 4,902 | 5,000 | 12,668 | 7.8 K to 12.7 K (+63.12 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 1.02 | 980 | 1,000 | 7,528 | 6.5 K to 7.5 K (+14.97 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 1.02 | 980 | 1,000 | 5,534 | 4.6 K to 5.5 K (+21.52 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.02 | 1,176 | 1,200 | 6,850 | 5.7 K to 6.9 K (+20.73 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.02 | 2,696 | 2,750 | 73,785 | 71.1 K to 73.8 K (+3.79 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.02 | 1,838 | 1,875 | 8,500 | 6.7 K to 8.5 K (+27.59 %) |
| Aug 13 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.03 | 6,500 | 6,695 | 241,964 | 235.5 K to 242 K (+2.76 %) |
| Aug 13 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.02 | 7,700 | 7,854 | 235,464 | 227.8 K to 235.5 K (+3.38 %) |
| Jul 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.01 | 1,260 | 1,274 | 227,764 | 226.5 K to 227.8 K (+0.56 %) |
| Jul 10 2007 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 1.01 | 1,260 | 1,274 | 52,376 | 51.1 K to 52.4 K (+2.46 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 1.15 | 4,348 | 5,000 | 7,766 | 3.4 K to 7.8 K (+127.21 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 1.15 | 4,348 | 5,000 | 7,766 | 3.4 K to 7.8 K (+127.21 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 1.15 | 870 | 1,001 | 6,548 | 5.7 K to 6.5 K (+15.32 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.15 | 1,043 | 1,199 | 5,674 | 4.6 K to 5.7 K (+22.52 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.15 | 2,391 | 2,750 | 71,089 | 68.7 K to 71.1 K (+3.48 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.15 | 2,391 | 2,750 | 71,089 | 68.7 K to 71.1 K (+3.48 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.15 | 1,630 | 1,875 | 6,662 | 5 K to 6.7 K (+32.39 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 1.15 | 870 | 1,001 | 4,554 | 3.7 K to 4.6 K (+23.62 %) |
| Jun 01 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.18 | 22,500 | 26,550 | 22,500 | |
| Jun 01 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.18 | 22,500 | 26,550 | 22,500 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | A | 1.18 | 15,000 | 17,700 | 15,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | BALDRIDGE ROBERT W | Director | Option Exercise | A | 1.18 | 45,000 | 53,100 | 45,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Option Exercise | A | 1.18 | 15,000 | 17,700 | 15,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 1.18 | 15,000 | 17,700 | 15,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | LANDINE MICHAEL J | Director | Option Exercise | A | 1.18 | 45,000 | 53,100 | 45,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | Bauer Kenneth | Director | Option Exercise | A | 1.18 | 15,000 | 17,700 | 15,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.18 | 45,000 | 53,100 | 45,000 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Option Exercise | A | 1.18 | 7,500 | 8,850 | 7,500 | |
| May 25 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Option Exercise | A | 1.18 | 7,500 | 8,850 | 7,500 | |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.95 | 1,260 | 1,200 | 226,504 | 225.2 K to 226.5 K (+0.56 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 2,000 | 0 | 225,244 | 227.2 K to 225.2 K (-0.88 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 1,450 | 0 | 2,000 | 550 to 2 K (+263.64 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 1,450 | 0 | 227,244 | 228.7 K to 227.2 K (-0.63 %) |
| Apr 09 2007 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.95 | 1,260 | 1,200 | 51,116 | 49.9 K to 51.1 K (+2.53 %) |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Grant | A | 0.00 | 3,418 | 0 | 3,418 | 0 to 3.4 K |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 1.02 | 977 | 1,000 | 5,678 | 4.7 K to 5.7 K (+20.78 %) |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.02 | 781 | 800 | 4,631 | 3.9 K to 4.6 K (+20.29 %) |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.02 | 1,709 | 1,750 | 68,698 | 67 K to 68.7 K (+2.55 %) |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 1.02 | 977 | 1,000 | 3,684 | 2.7 K to 3.7 K (+36.09 %) |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.02 | 1,831 | 1,875 | 5,032 | 3.2 K to 5 K (+57.20 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.04 | 45,000 | 46,800 | 45,000 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.99 | 300 | 297 | 228,694 | 228.4 K to 228.7 K (+0.13 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.00 | 7,700 | 7,700 | 228,394 | 220.7 K to 228.4 K (+3.49 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.01 | 16,000 | 16,160 | 220,694 | 204.7 K to 220.7 K (+7.82 %) |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 1.04 | 35,000 | 36,400 | 35,000 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Option Exercise | A | 1.04 | 45,000 | 46,800 | 45,000 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 1.04 | 45,000 | 46,800 | 45,000 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Option Exercise | A | 1.04 | 45,000 | 46,800 | 45,000 | |
| Mar 14 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.04 | 110,000 | 114,400 | 110,000 | |
| Jan 10 2007 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.94 | 1,260 | 1,189 | 49,856 | 48.6 K to 49.9 K (+2.59 %) |
| Jan 10 2007 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.94 | 1,260 | 1,189 | 204,694 | 203.4 K to 204.7 K (+0.62 %) |
| Jan 05 2007 | GTCB | rEVO Biologics, In ... | LFB Biotechnologies S.A.S.U. | 10% Owner | Buy | P | 1.23 | 3,630,000 | 4,464,900 | 3,630,000 | 0 to 3.6 M |
| Jan 05 2007 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Buy | P | 1.23 | 3,630,000 | 4,464,900 | 3,630,000 | 0 to 3.6 M |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Grant | A | 1.11 | 901 | 1,000 | 4,701 | 3.8 K to 4.7 K (+23.71 %) |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.11 | 721 | 800 | 3,850 | 3.1 K to 3.9 K (+23.04 %) |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 1.11 | 1,577 | 1,750 | 66,989 | 65.4 K to 67 K (+2.41 %) |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.11 | 1,689 | 1,875 | 4,818 | 3.1 K to 4.8 K (+53.98 %) |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Grant | A | 1.11 | 901 | 1,000 | 2,701 | 1.8 K to 2.7 K (+50.06 %) |
| Dec 22 2006 | GTCB | rEVO Biologics, In ... | Bechon Christian | Director | Option Exercise | A | 1.10 | 22,500 | 24,750 | 22,500 | |
| Dec 22 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Sell | S | 1.10 | 7,500 | 8,221 | 64,134 | 71.6 K to 64.1 K (-10.47 %) |
| Nov 17 2006 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Option Exercise | A | 0.89 | 22,500 | 20,025 | 22,500 | |
| Nov 17 2006 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Grant | A | 1.24 | 1,129 | 1,400 | 3,129 | 2 K to 3.1 K (+56.45 %) |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Option Exercise | A | 0.89 | 22,500 | 20,025 | 22,500 | |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | Bauer Kenneth | Director | Option Exercise | A | 0.89 | 22,500 | 20,025 | 22,500 | |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.24 | 2,621 | 3,250 | 65,412 | 62.8 K to 65.4 K (+4.17 %) |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 0.89 | 22,500 | 20,025 | 22,500 | |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.24 | 1,129 | 1,400 | 3,129 | 2 K to 3.1 K (+56.45 %) |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Buy | P | 1.24 | 800 | 992 | 1,800 | 1,000 to 1.8 K (+80.00 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.05 | 4,230 | 4,442 | 203,434 | 199.2 K to 203.4 K (+2.12 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.06 | 8,920 | 9,455 | 199,204 | 190.3 K to 199.2 K (+4.69 %) |
| Nov 06 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.07 | 1,150 | 1,231 | 190,284 | 189.1 K to 190.3 K (+0.61 %) |
| Oct 24 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.99 | 1,260 | 1,253 | 48,596 | 47.3 K to 48.6 K (+2.66 %) |
| Oct 13 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.99 | 1,174 | 1,168 | 189,134 | 188 K to 189.1 K (+0.62 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 1.23 | 1,000 | 1,230 | 89,226 | 88.2 K to 89.2 K (+1.13 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 1.23 | 1,000 | 1,230 | 47,336 | 46.3 K to 47.3 K (+2.16 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.86 | 1,260 | 1,082 | 46,336 | 45.1 K to 46.3 K (+2.80 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 1.23 | 1,000 | 1,230 | 187,960 | 187 K to 188 K (+0.53 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.86 | 1,260 | 1,082 | 186,960 | 185.7 K to 187 K (+0.68 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 1.23 | 1,000 | 1,230 | 85,700 | 84.7 K to 85.7 K (+1.18 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Payment of Exercise | F | 1.23 | 156 | 192 | 33,548 | 33.7 K to 33.5 K (-0.46 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Grant | A | 1.23 | 1,000 | 1,230 | 33,704 | 32.7 K to 33.7 K (+3.06 %) |
| Aug 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 1.23 | 1,000 | 1,230 | 71,634 | 70.6 K to 71.6 K (+1.42 %) |
| Apr 11 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.87 | 1,260 | 1,092 | 185,700 | 184.4 K to 185.7 K (+0.68 %) |
| Apr 11 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Buy | J | 0.87 | 1,260 | 1,092 | 45,076 | 43.8 K to 45.1 K (+2.88 %) |
| Mar 21 2006 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Sell | S | 1.01 | 20,000 | 20,100 | 32,704 | 52.7 K to 32.7 K (-37.95 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Option Exercise | A | 1.03 | 35,000 | 36,050 | 35,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior VP and CFO | Grant | A | 0.00 | 41,821 | 0 | 84,700 | 42.9 K to 84.7 K (+97.53 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Option Exercise | A | 1.03 | 50,000 | 51,500 | 50,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | Scotland Richard A | Senior VP, Regulato ... | Grant | A | 0.00 | 24,653 | 0 | 68,469 | 43.8 K to 68.5 K (+56.26 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 1.03 | 50,000 | 51,500 | 50,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 0.00 | 40,664 | 0 | 88,226 | 47.6 K to 88.2 K (+85.50 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Option Exercise | A | 1.03 | 50,000 | 51,500 | 50,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | Senior VP, Operatio ... | Grant | A | 0.00 | 39,257 | 0 | 52,704 | 13.4 K to 52.7 K (+291.94 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Option Exercise | A | 1.03 | 25,000 | 25,750 | 25,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | Senior VP and Gener ... | Grant | A | 0.00 | 34,715 | 0 | 70,634 | 35.9 K to 70.6 K (+96.65 %) |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.03 | 90,000 | 92,700 | 90,000 | |
| Mar 14 2006 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 90,923 | 0 | 184,440 | 93.5 K to 184.4 K (+97.23 %) |
| Dec 30 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.39 | 723 | 1,008 | 93,517 | 92.8 K to 93.5 K (+0.78 %) |
| Dec 30 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Gift | G | 0.00 | 550 | 0 | 92,794 | 93.3 K to 92.8 K (-0.59 %) |
| Dec 30 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.12 | 1,048 | 1,176 | 93,344 | 92.3 K to 93.3 K (+1.14 %) |
| Nov 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.62 | 100 | 162 | 62,791 | 62.7 K to 62.8 K (+0.16 %) |
| Nov 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.62 | 1,800 | 2,912 | 62,691 | 60.9 K to 62.7 K (+2.96 %) |
| Nov 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.61 | 700 | 1,127 | 60,891 | 60.2 K to 60.9 K (+1.16 %) |
| Nov 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.60 | 300 | 480 | 60,191 | 59.9 K to 60.2 K (+0.50 %) |
| Nov 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.59 | 100 | 159 | 59,891 | 59.8 K to 59.9 K (+0.17 %) |
| Jul 07 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.37 | 736 | 1,007 | 92,296 | 91.6 K to 92.3 K (+0.80 %) |
| Jun 02 2005 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Buy | P | 1.34 | 2,000 | 2,680 | 7,000 | 5 K to 7 K (+40.00 %) |
| May 26 2005 | GTCB | rEVO Biologics, In ... | BULLOCK FRANCIS J | Director | Option Exercise | A | 1.29 | 22,500 | 29,025 | 22,500 | |
| May 26 2005 | GTCB | rEVO Biologics, In ... | TUCK ALAN W | Director | Option Exercise | A | 1.29 | 22,500 | 29,025 | 22,500 | |
| May 16 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.32 | 3,000 | 3,960 | 59,791 | 56.8 K to 59.8 K (+5.28 %) |
| May 16 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Buy | P | 1.39 | 1,000 | 1,390 | 42,879 | 41.9 K to 42.9 K (+2.39 %) |
| May 04 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.95 | 3,000 | 2,850 | 91,560 | 88.6 K to 91.6 K (+3.39 %) |
| May 04 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 0.96 | 2,000 | 1,920 | 88,560 | 86.6 K to 88.6 K (+2.31 %) |
| Apr 11 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 0.94 | 1,260 | 1,184 | 86,560 | 85.3 K to 86.6 K (+1.48 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 1.71 | 39,000 | 66,690 | 39,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Grant | A | 0.00 | 6,459 | 0 | 47,562 | 41.1 K to 47.6 K (+15.71 %) |
| Mar 15 2005 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Buy | P | 1.75 | 5,000 | 8,750 | 56,791 | 51.8 K to 56.8 K (+9.65 %) |
| Mar 15 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.80 | 4,200 | 7,560 | 85,300 | 81.1 K to 85.3 K (+5.18 %) |
| Mar 15 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | P | 1.79 | 1,100 | 1,969 | 81,100 | 80 K to 81.1 K (+1.38 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 1.71 | 75,000 | 128,250 | 75,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Grant | A | 0.00 | 13,757 | 0 | 80,000 | 66.2 K to 80 K (+20.77 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 1.71 | 27,000 | 46,170 | 27,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Grant | A | 0.00 | 5,222 | 0 | 35,919 | 30.7 K to 35.9 K (+17.01 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | SVP, Operations | Option Exercise | A | 1.71 | 55,000 | 94,050 | 55,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | SVP, Operations | Grant | A | 0.00 | 6,486 | 0 | 13,447 | 7 K to 13.4 K (+93.18 %) |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 1.71 | 39,000 | 66,690 | 39,000 | |
| Feb 17 2005 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Grant | A | 0.00 | 6,750 | 0 | 41,879 | 35.1 K to 41.9 K (+19.21 %) |
| Jan 10 2005 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.44 | 692 | 996 | 66,243 | 65.6 K to 66.2 K (+1.06 %) |
| Jan 10 2005 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.44 | 274 | 395 | 30,697 | 30.4 K to 30.7 K (+0.90 %) |